Cargando…
Neuropathic cancer pain: prevalence, pathophysiology, and management
Neuropathic cancer pain (NCP) is caused by nerve damage attributable to the cancer per se, and/or treatments including chemotherapy, radiotherapy, and surgery; the prevalence is reported to be as high as 40%. The etiologies of NCP include direct nerve invasion or nerve compression by the cancer, neu...
Autores principales: | Yoon, So Young, Oh, Jeeyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234399/ https://www.ncbi.nlm.nih.gov/pubmed/29929349 http://dx.doi.org/10.3904/kjim.2018.162 |
Ejemplares similares
-
Pathophysiology of Post-Traumatic Trigeminal Neuropathic Pain
por: Korczeniewska, Olga A., et al.
Publicado: (2022) -
Evaluation of neuropathic pain with diverse pathophysiologies in childhood cancers
por: Sen, Hilal Susam, et al.
Publicado: (2022) -
Characteristics of Diverse Verbal Pain Descriptors in South Korean Patients With Peripheral Neuropathic Pain: ‘Jeorim’ (Tingling) and ‘Sirim’ (Cold) as Key Neuropathic Pain Descriptors
por: Choi, Kyomin, et al.
Publicado: (2023) -
Quantum Mechanical Aspects in the Pathophysiology of Neuropathic Pain
por: Nawafleh, Sager, et al.
Publicado: (2022) -
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models
por: Khan, Nemat, et al.
Publicado: (2013)